Santhera Initiates Collaboration with the European Vision Institute Clinical Research Network in LHON
Under the collaboration, Santhera will receive data on the change in vision over time in untreated LHON patients from selected EVICR.net centers. This data will be compared to the vision outcomes data currently being collected from physicians around the world who are treating LHON patients with Raxone® in clinical practice.
"Lack of natural history data is a general shortcoming in clinical research of rare diseases and a limitation in the development of orphan drugs", commented Thomas Meier, CEO of Santhera. "We have initiated this collaboration with EVICR.net to increase our understanding of changes in vision in LHON patients, including spontaneous recovery after severe vision loss. We expect to integrate these data as a comparator group in a revised MAA for Raxone® in the treatment of LHON that we plan to submit as early as the first quarter next year."
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.